Clinical and radiologic characteristics in the hyperglycemic and nonhyperglycemic groups
| Hyperglycemic Patients (n = 34) | Nonhyperglycemic Patients (n = 60) | P Value | |
|---|---|---|---|
| Age (yr) | 60 | 62 | .65 |
| 57–61 | 55–67 | ||
| Thrombolytic treatment (%) | 74 | 63 | .38 |
| Baseline NIHSS score | 17 | 14 | .003 |
| 15–20 | 11–16 | ||
| Baseline SGL (mmol/L) | 8.7 | 5.8 | <.0001 |
| 7.8–10.9 | 5.4–6.2 | ||
| Time to initial MRI (min) | 132 | 150 | .22 |
| 112–157 | 128–176 | ||
| Time to follow-up MRI (hr) | 32 | 28 | .13 |
| 26.5–45.7 | 23–37.3 | ||
| Recanalized patients (n, %) | 23 | 44 | .70 |
| 68% | 72% | ||
| Initial DWI volume (cm3) | 29 | 18.3 | .08 |
| 7.9, 47.5 | 16.6, 55.3 | ||
| Mean ADC in initial DWI vol (× 10−6 mm2/s) | 652 | 633 | .56 |
| 609–694 | 580–674 | ||
| Final DWI volume (cm3) | 74.5 | 31.8 | .004 |
| 34.8, 134.1 | 20.4, 57 | ||
| Predicted final volume (cm3) | 50.5 | 39.7 | .25 |
| 21.3, 123.8 | 15.9, 82.2 | ||
| Predicted infarct growth (cm3) | 29.3 | 23.5 | .47 |
| (0.9, 53.3) | (5.4, 44.5) | ||
| Observed infarct growth (cm3) | 40.2 | 9.2 | .0003 |
| (10.6, 85) | (3.2, 30.8) | ||
| Spared tissue-at-risk (cm3) | −5.9 | 7 | .0025 |
| −55.1, 8.5 | −3.6, 25.2 |
Note:Numbers are shown as the median and interquartile range.